KDR and neoplasm: Multiparametric CEUS with VEGFR2-targeted MB has demonstrated to be a highly sensitive tool for monitoring therapy effects in a range of tumour entities: In a mouse model of hepatocellular carcinoma, early therapeutic effects of the tyrosine kinase inhibitor sorafenib were analysed [25].